Genenta Science S.P.A. ADR (GNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,388 | -9,644 | -12,604 | -8,932 | -6,542 |
| Depreciation Amortization | 32 | 48 | 46 | 7 | 6 |
| Accounts payable and accrued liabilities | 1,484 | 35 | -788 | 1,058 | -432 |
| Other Working Capital | -1,786 | 1,858 | -452 | 253 | -2,300 |
| Other Operating Activity | -112 | 950 | 1,671 | -201 | 1,036 |
| Operating Cash Flow | $-7,770 | $-6,753 | $-12,127 | $-7,816 | $-8,232 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -16,446 | 7,453 | -16,103 | N/A | N/A |
| PPE Investments | -9 | -5 | -15 | -29 | -11 |
| Investing Cash Flow | $-16,455 | $7,448 | $-16,118 | $-29 | $-11 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 8,486 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 16,731 | 293 | 1 | N/A | 34,005 |
| Financing Cash Flow | $25,216 | $293 | $1 | $N/A | $34,005 |
| Exchange Rate Effect | 80 | -25 | -7 | N/A | N/A |
| Beginning Cash Position | 5,184 | 3,995 | 32,247 | 39,236 | 18,297 |
| End Cash Position | 6,254 | 4,958 | 3,995 | 31,392 | 44,059 |
| Net Cash Flow | $1,070 | $963 | $-28,252 | $-7,844 | $25,762 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,770 | -6,753 | -12,127 | -7,816 | -8,232 |
| Capital Expenditure | -9 | -5 | -15 | -29 | -11 |
| Free Cash Flow | -7,779 | -6,757 | -12,142 | -7,844 | -8,243 |